Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
12:35pPfizer, BioNTech Launch Clinical Study of Omicron-Specific COVID-19 Vaccine
MT
07:35aBerenberg Bank Adjusts AbbVie's Price Target to $115 From $105, Maintains Hold Rating
MT
07:10aPfizer, BioNTech to Study Omicron-Based COVID-19 Vaccine in Adults
MT
07:08aPfizer, BioNTech Start Clinical Study On Omicron-based Vaccine
MT
04:31aGermany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1
RE
01:33aRoche's Spinal Muscular Atrophy Drug Wins US FDA Priority Review
MT
01:00aRoche Announces U.S. Food and Drug Administration Grants Evrysdi Priority Review for Tr..
CI
01/24Pfizer Urged To Ramp Up COVID-19 Pill Supply In Developing Countries, Aid Generics Entr..
MT
01/24US FDA Restricts Use of Eli Lilly, Regeneron's COVID-19 Treatments
MT
01/24U.S. FDA limits use of Regeneron, Lilly COVID-19 antibody treatments
RE
01/24Pfizer Inc. and BioNTech SE Publish Data from Two Laboratory Studies on Covid-19 Vaccin..
CI
01/24Health Care Stocks Declining This Afternoon
MT
01/24Health Care Stocks Dragged Lower in Broad-Based Equities Selloff
MT
01/24Chile to purchase 2 million Moderna COVID-19 vaccine doses
RE
01/24FDA to Restrict Monoclonal Antibodies Manufactured by Eli Lilly, Regeneron Pharmaceutic..
MT
01/24Roche Says Data Show Faricimab Improved Vision in Final-Stage Studies
MT
01/24Morgan Stanley Adjusts AbbVie's Price Target to $142 from $124, Keeps Overweight Rating
MT
01/24Morgan Stanley Adjusts Eli Lilly and Co.'s Price Target to $272 from $275, Keeps Overwe..
MT
01/24EU Drug Regulator Reportedly Will Decide on Approval of Pfizer's COVID-19 Pill by End o..
MT
01/24Anixa Biosciences Says New COVID-19 Compound Shows Promise in Preliminary Lab Test
MT
01/24The Lancet Publishes Studies Showing Roche’s Faricimab Improved and Maintained Vis..
CI
01/24OPKO Health Shares Drop 20% After Complete Response Letter for Somatrogon
DJ
01/24Health Care Stocks Retreat Premarket Monday
MT
01/24Health Care
MT
01/24EU Medicines Watchdog to Issue Decision on Pfizer's COVID-19 Pill in January
MT
01/24Oxford Says Mixed Vaccine Schedules Offer Strong Booster Responses After 2 Doses Of Cor..
RE
01/24EU regulator set to rule on Pfizer COVID pill by end-Jan, ahead of Merck
RE
01/24Pfizer-BioNTech Booster Shot Effective Against Omicron, New Study Finds
MT
01/24Israeli Study Finds Fourth Vaccine Dose Increases Resistance To COVID-19 In People Over..
MT
01/24Pfizer CEO Says Annual COVID-19 Vaccine Preferable Than Frequent Boosters
MT
01/24ROCHE HOLDINGS AG : JP Morgan remains Neutral
MD
01/21Innovent and Eli Lilly and Company Announces Final Clinical Results and Biomarker Analy..
CI
01/21Pzifer, OPKO Health Evaluating FDA's Complete Response Letter on Growth Hormone Replace..
MT
01/21AbbVie Receives FDA Second Indication Approval for Skyrizi to Treat Adults with Active ..
MT
01/21Pfizer Inc. and OPKO Health, Inc. Provide Update on the Biologics License Application f..
CI
01/21Moderna's Valuation Has Come 'Back to Earth,' Become More Reasonable, BofA Securities S..
MT
01/21GSK, Vir ramping up U.S. output of COVID antibody drug
RE
01/21Pfizer-BioNTech's COVID-19 Vaccine Gets WHO Backing for Kids 5 to 11 Years Old
MT
01/21Glaxo Unit Valuation Boost Looks Less Likely as Unilever Walks -- Market Insight
DJ
01/21Pfizer's COVID-19 Vaccine Gets WHO Backing for Kids Ages 5 to 11
MT
01/21Alzheimer's patient groups protest U.S. Medicare coverage proposal limiting use of new ..
RE
01/21Japan OKs Pfizer/BioNTech's COVID-19 Vaccine For Children
MT
01/21DZ Bank Upgrades Eli Lilly and Co. to Buy From Hold; Price Target is $291
MT
01/21Japan Clears Use of Pfizer's COVID-19 Vaccine on Children
MT
01/20Unilever Shareholder Calls for Improvement in Performance After Failed GSK-Pfizer Bid
MT
01/20Barclays Adjusts AbbVie's Price Target to $133 from $118, Keeps Equalweight Rating
MT
01/20Syapse, Inc. Extends Collaboration with Pfizer to Continue to Generate Real-World Evide..
CI
01/20Opko Health, Pfizer Secure Japan's Approval for Pediatric Growth Hormone Deficiency Dru..
MT
01/20EMA Says Spikevax Product Information To Be Updated To Include Paraesthesia As Rare Sid..
RE
01/20Africa CDC to Seek Supplies of Merck & Co.'s COVID-19 Pill
MT
1  2  3  4  5  6  7  8  9  10Next
Official Publications
Upcoming event on JOHNSON & JOHNSON